Peroxynitrite induces an alternative NF-κB activation pathway in L8 rat myoblasts

Antioxidants and Redox Signaling

Volumn 8, Issue 3-4, 2006, Pages 639-652

  Bar Shai, Marina ^a   Reznick, Abraham Z ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; EPIGALLOCATECHIN GALLATE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LUCIFERASE; PEROXYNITRITE; PROTEASOME INHIBITOR; SERINE; SYNAPTOTAGMIN; TYROSINE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DISEASE EXACERBATION; DISSOCIATION; INFLAMMATION; MUSCLE CELL; MYOBLAST; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; SKELETAL MUSCLE;

ANIMALS; CELL LINE; CELLS, CULTURED; I-KAPPA B PROTEINS; INFLAMMATION; LEUPEPTINS; MUSCLE CELLS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEROXYNITROUS ACID; RATS; SUBCELLULAR FRACTIONS; TYROSINE;

ANIMALIA;

EID: 33646703558     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.639     Document Type: Article

References (60)

1. Andreadis AA, Hazen SL, Comhair SA, and Erzurum SC. Oxidative and nitrosative events in asthma. Free Radic Biol Med 35: 213-225, 2003.
2. Attaix D, Aurousseau E, Combaret L, Kee A, Larbaud D, Ralliere C, Souweine B, Taillandier D, and Tilignac T. Ubiquitin-proteasome-dependent proteolysis in skeletal muscle. Reprod Nutr Dev 38: 153-165, 1998.
3. Bar-Shai M, Carmeli E, Coleman R, Rozen N, Perek S, Fuchs D, and Reznick AZ. The effect of hindlimb immobilization on acid phosphatase, metalloproteinases and nuclear factor-kappaB in muscles of young and old rats. Mech Ageing Dev 126: 289-297, 2005.
4. Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32: 797-803, 2002.
5. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844, 1996.
6. Byun MS, Jeon KI, Choi JW, Shim JY, and Jue DM. Dual effect of oxidative stress on NF-kappaB activation in HeLa cells. Exp Mol Med 34: 332-339, 2002.
7. Carmeli E, Coleman R, and Reznick AZ. The biochemistry of aging muscle. Exp Gerontol 37: 477-489, 2002.
8. Cooke CL and Davidge ST. Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 282: C395-C402, 2002.
9. Darley-Usmar V and Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 13: 649-662, 1996.
10. Dedon PC and Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 423: 12-22, 2004.
11. Drew B and Leeuwenburgh C. Aging and the role of reactive nitrogen species. Ann NY Acad Sci 959: 66-81, 2002.
12. Ducrocq C, Blanchard B, Pignatelli B, and Ohshima H. Peroxynitrite: an endogenous oxidizing and nitrating agent. Cell Mol Life Sci 55: 1068-1077, 1999.
13. Eiserich JP, Patel RP, and O'Donnell VB. Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 19: 221-357, 1998.
14. Feelisch M. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch Pharmacol 358: 113-122, 1998.
15. Glass DJ. Molecular mechanisms modulating muscle mass. Trends Mol Med 9: 344-350, 2003.
16. .: a pulse radiolysis study. Free Radic Biol Med 117: 12078-12084, 1995.
17. 2+ pump isoforms SERCA2b and SERCA3a. Am J Physiol Cell Physiol 285: C1537-C1543, 2003.
18. Grune T, Klotz LO, Geiche J, Rudeck M, and Sies H. Protein oxidation and proteolysis by the nonradical oxidants singlet oxygen or peroxynitrite. Free Radic Biol Med 30: 1243-1253, 2001.
19. Hay RT, Vuillard L, Desterro JM, and Rodriguez MS. Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha. Philos Trans R Soc Lond B Biol Sci 354: 1601-1609, 1999.
20. Hunter RB and Kandarian SC. Disruption of either the Nfkb1 or the Bc13 gene inhibits skeletal muscle atrophy. J Clin Invest 114: 1504-1511, 2004.
21. Jackman RW and Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287: C834-C843, 2004.
22. Janssen-Heininger YMW, Macara I, and Mossman BT. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am J Respir Cell Mol Biol 20: 942-952, 1999.
23. Janssen-Heininger YMW, Poynter ME, and Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28: 1317-1327, 2000.
24. Karin M and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663, 2000.
25. Katsuyama K, Shichiri M, Marumo F, and Hirata Y. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. Anerioscler Thromb Vasc Biol 18: 1796-1802, 1998.
26. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, and Roussos C. Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. Am J Respir Cell Mol Biol 26: 587-593, 2002.
27. Kuno K and Matsushima K. The IL-1 receptor signaling pathway. J Leukoc Biol 56: 542-547, 1994.
28. Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Ohishi S, Steinbrecher UP, and Heinecke JW. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem 272: 1433-1436, 1997.
29. Lepore DA, Stewart AG, Tomasi A, Anderson RL, Hurley JV, and Morrison WA. The survival of skeletal muscle myoblasts in vitro is sensitive to a donor of nitric oxide and superoxide, SIN-1, but not to nitric oxide or peroxynitrite alone. Nitric Oxide 3: 273-280, 1999.
30. Li YP and Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 279: R1165-R1170, 2000.
31. Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 4: 441-458, 2000.
32. Mahabeleshwar GH and Kundu GC. Tyrosine kinase p561ck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation. J Biol Chem 278: 52598-52612, 2003.
33. Malan D, Levi RC, Alloatti G, Marcantoni A, Bedendi I, and Gallo MP. Cyclic AMP and cyclic GMP independent stimulation of ventricular calcium current by peroxy nitrite donors in guinea pig myocytes. J Cell Physiol 197: 284- 296, 2003.
34. Marcell TJ. Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci 58: M911-M916, 2003.
35. Matata BM and Galinanes M. Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity. J Biol Chem 277: 2330-2335, 2002.
36. Matthews JR, Botting CH, Panico M, Morris HR, and Hay RT. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res 24: 2236-2242, 1996.
37. Monteiro HP. Signal transduction by protein tyrosine nitration: competition or cooperation with tyrosine phosphorylation-dependent signaling events? Free Radic Biol Med 33: 765-773, 2002.
38. Mukhopadhyay A, Manna SK, and Aggarwal BB. Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IκBα. Comparison with tumor necrosis factor-alpha. J Biol Chem 275: 8549-8555, 2000.
39. Muller JM, Ziegler-Heitbrock HW, and Baeuerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233-256, 1993.
40. Natarajan R, Fisher BJ, Jones DG, and Fowler III AA. Atypical mechanism of NF-kappaB activation during reoxygenation stress in microvascular endothelium: a role for tyrosine kinases. Free Radic Biol Med 33: 962-973, 2002.
41. Nomura Y. NF-κB activation and IκB α dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci 68: 1695-1701, 2001.
42. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866, 1999.
43. Pahlavani MA and Harris MD. Effect of in vitro generation of oxygen free radicals on T cell function in young and old rats. Free Radic Biol Med 25: 903-913, 1998.
44. Pannala AS, Rice-Evans CA., Halliwell B, and Singh S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem Biophys Res Commun 232: 164-168, 1997.
45. Pignone A, Fiori G, Del Rosso A, Generini S, and Matucci-Cerinic M. The pathogenesis of inflammatory muscle diseases: on the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis. Autoimmun Rev 1: 226-232, 2002.
46. Radi R, Peluffo G, Alvarez MN, Naviliat M, and Cayota A. Unraveling peroxynitrite formation in biological systems Free Radic Biol Med 30: 463-488, 2001.
47. Reynaert NL, Ckless K, Korn SH, Vos N, Guala AS, Wouters EF, van der Vliet A, and Janssen-Heininger YJM. Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc Natl Acad Sci USA 101: 8945-8950, 2004.
48. Robbins RA, Hadeli K, Nelson D, Sato E, and Hoyt JC. Nitric oxide, peroxynitrite, and lower respiratory tract inflammation. Immunopharmacology 48: 217-221, 2000.
49. Rosenkranz B, Winkelmann BR, and Parnham MJ. Clinical pharmacokinetics of molsidomine. Clin Pharmacokinet 30: 372-384, 1996.
50. Rubin H. Cancer cachexia: its correlations and causes. Proc Natl Acad Sci USA 10: 5384-5389, 2003.
51. Sen CK, Khanna S, Reznick AZ, Roy S, and Packer L. Glutathione regulation of tumor necrosis factor-alpha-induced NF-kappa B activation in skeletal muscle-derived L6 cells. Biochem Biophys Res Commun 237: 645-649, 1997.
52. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140-141: 105-112, 2003.
53. Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, and Aggarwal BB. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. J Biol Chem. 278: 24233- 24241, 2003.
54. Torreilles F, Salman-Tabcheh S, Guerin M, and Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res Rev 30: 153-163, 1999.
55. 2+-ATPaSe in skeletal muscle. Biochem J 340: 657-669, 1999.
56. Virag L, Szabo E, Gergely P, and Szabo C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett 140-141: 113-124, 2003.
57. Williams G, Becker L, Bryant D, Willis S, and Giroir BP. Effects of transforming growth factor-beta 1 on nitric oxide synthesis by C2C12 skeletal myocytes. Am J Physiol Regul Integr Comp Physiol 270: R145-R152, 1996.
58. Williams G, Brown T, Becker L, Prager M, and Giroir BP. Cytokine-induced expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am J Physiol 267: R1020-R1025, 1994.
59. Xie QW and Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol 56: 576-582, 1994.
60. Zwacka RM, Zhang Y, Zhou W, Halldorson J, and Engelhardt JF. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation. Hepatology 28: 1022-1030, 1998.